FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Professur für Translationale Frauenheilkunde und Geburtshilfe
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Department of Obstetrics and Gynaecology
Lehrstuhl für Geburtshilfe und Frauenheilkunde
Overview
Publications
(880)
Research Grants
(4)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis (2019)
Shu X, Wu L, Khankari NK, Shu XO, Wang TJ, Michailidou K, Bolla MK, et al.
Journal article
The genetic interplay between body mass index, breast size and breast cancer risk: a Mendelian randomization analysis (2019)
Ooi BNS, Loh H, Ho PJ, Milne RL, Giles G, Gao C, Kraft P, et al.
Journal article
Relevance of tumour-infiltrating lymphocytes, PD-1 and PD-L1 in patients with high-risk, nodal-metastasised breast cancer of the German Adjuvant Intergroup Node–positive study (2019)
Noske A, Möbus V, Weber K, Schmatloch S, Weichert W, Köhne CH, Solbach C, et al.
Journal article
Sorafenib in combination with docetaxel as first-line therapy for HER2-negative metastatic breast cancer: Final results of the randomized, double-blind, placebo-controlled phase II MADONNA study (2019)
Mavratzas A, Baek S, Gerber B, Schmidt M, Moebus , Foerster F, Grischke EM, et al.
Journal article
Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk (2019)
Vachon CM, Scott CG, Tamimi RM, Thompson DJ, Fasching P, Stone J, Southey MC, et al.
Journal article
Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto (2019)
Laakmann E, Witzel I, Fasching P, Rezai M, Schem C, Solbach C, Tesch H, et al.
Journal article
Influence of PIK3CA mutations on breast cancer proliferation, lymphocyte infiltration and clinical outcome: Pooled analysis of 484 patients from three prospective multicentre GBG trials (2019)
Jank P, Loibl S, Fasching P, Karn T, Marme F, Mueller V, Schem C, et al.
Conference contribution
Impact of objective response (OR) on patient-reported outcomes (PRO) in patients (pts) with advanced breast cancer (ABC) and a germline BRCA1/2 (gBRCA) mutation in the phase III EMBRACA trial (2019)
Fasching P, Quek RGW, Bhattacharyya H, Hurvitz SA, Rugo HS, Ettl J
Conference contribution
Evaluation of pathological complete response as a trial-level surrogate for long-term survival outcomes among triple-negative breast cancer patients receiving neoadjuvant therapy (2019)
Huang M, Qi CZ, Ramsey S, Briggs A, Zhao J, Haiderali A, Karantza V, et al.
Conference contribution
A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO) (2019)
Turner NC, Telli ML, Rugo HS, Mailliez A, Ettl J, Grischke EM, Mina LA, et al.
Journal article
‹
1
...
38
39
40
41
42
...
80
›